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Abstract  
 Zika virus (ZIKV) is mainly transmitted to humans by Aedes species mosquitoes and is 
associated with serious pathological disorders including microcephaly in newborns and Guillain-
Barré syndrome in adults. Currently, there is no vaccine or anti-ZIKV drug available for preventing 
or controlling ZIKV infection. An attractive drug-target for ZIKV treatment is a two-compartment 
(NS2B/NS3) serine protease that processes viral polyprotein during infection. Here, conventional 
molecular dynamics (MD) simulations of the ZIKV protease in complex with peptide substrate 
(TGKRS) sequence at the C-terminus of NS2B show that the substrate is in the active conformation 
for cleavage reaction by ZIKV protease. Hybrid quantum mechanics/molecular mechanics 
(QM/MM) umbrella sampling simulation (PM6/ff14SB) of acylation results reveal that proton 
transfer from S135 to H51 and nucleophilic attack on the substrate by S135 are concerted. The 
rate-limiting step involves the formation of a tetrahedral intermediate. In addition, the single-point 
energy QM/MM calculations, precisely at the coupled cluster theory (LCCSD(T)/(aug)-cc-pVTZ), 
were calculated to correct the potential energy profiles for the first step of the acylation process. 
The average computed activation barrier at this level of theory is 16.3 kcal mol-1. Therefore, the 
computational approaches presented here are helpful for further designing of NS2B/NS3 inhibitors 
based on transition state analogues. 
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Introduction 
 Zika virus (ZIKV) is primarily transmitted to humans through the bite of infected Aedes 
mosquitoes and has become a global public health problem. ZIKV infection appears to produce 
higher risk of complications including neurologic symptoms in adults and microcephaly in 
newborns. ZIKV was first isolated from rhesus monkey cells in 1947 in Uganda.1 Additionally, it 
can be further classified into two genotypes, African and Asian, based on phylogenetic analysis.2 
ZIKV is a member of the Flavivirus genus and Flaviviridae family. Its genome is similar to other 
flaviviruses, including West Nile virus (WNV), Dengue virus (DENV), Japanese encephalitis virus 
(JEV) and yellow fever virus (YFV).3 ZIKV is an RNA virus containing a single-stranded positive-
sense RNA (ssRNA) genome of approximately 11 Kb. After infection of ZIKV into the host cells, 
its ssRNA genome is then translated into a large single polyprotein precursor. This polyprotein 
precursor is subsequently processed into three structural proteins (capsid (C), 
premembrane/membrane (prM), and envelope (E)), and seven nonstructural (NS) proteins (NS1, 
NS2A, NS2B, NS3, NS4A, NS4B, and NS5) through the activity of both host and viral proteases. 
Note that the structural and nonstructural proteins are responsible for forming the virus particle 
and viral replication process, respectively.4 
 Clinically, the symptoms of the ZIKV infection have been reported to be similar to those 
observed for other arboviruses, which are commonly known as Zika fever.5 Due to asymptomatic 
or mild symptoms of ZIKV infection, the disease was not considered originally as a relevant human 
pathogen and consequently research into the virus was neglected for more than 50 years by the 
scientific community.1, 6 This situation changed dramatically in recent years, as in 2015 the ZIKV 
infection increased suddenly, becoming epidemic regions in South America especially in Brazil, 
and spread quickly to other countries around the world.7, 8 More seriously, there is now growing 
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scientific evidence indicating a relationship between ZIKV infection and fetal microcephaly in 
newborns,9, 10 and Guillain–Barré syndrome in adults.11, 12 Thus, these phenomena have driven 
researchers to look at this ‘relatively harmless’ virus with new perspective.13-15 Unfortunately, 
neither vaccine nor antiviral drug is currently available to combat with ZIKV, an intended attempt 
of researchers is now focused on a rapid understanding of the structural biology of the ZIKV. 
 Similar to other flaviviral NS3 proteins, the ZIKV NS3 protein (~70 kDa) consists of two 
functional domains comprising a protease domain and a helicase domain. The C-terminal region 
of NS3 contains a helicase–nucleoside triphosphatase (NTPase), whereas the N-terminal region of 
the NS3 protein encodes a chymotrypsin-like serine protease that specifically recognizes substrates 
containing amino acid residues with basic character such as arginine at the P1 position and lysine 
at the P2 position.16, 17 Based on the common structures of flavivirus proteases, the active form of 
the ZIKV protease comprises the N-terminal protease domain of NS3 protein, which carries the 
catalytic triad (H51, D75 and S135), and the membrane-bound NS2B protein. Assembly of NS3 
protease with the membrane-bound NS2B rearranges the NS3 active site to achieve the optimal 
geometrical configuration for catalysis, as has been observed for related flavivirus proteases.18, 19 
The NS2B/NS3 serine protease is necessary for viral polyprotein processing to yield mature 
structural and nonstructural proteins; hence, this enzyme is a particularly promising flavivirus 
therapeutic target for the design of novel antiviral agents.20-22 
 Recently, several research groups have reported the X-ray crystal structures of the NS3 
protease domain of ZIKV in complex with the membrane-bound NS2B (~40 amino acids), 
covalently bonded via a glycine-rich linker to the N-terminus of NS3, which shows strong 
peptidolytic activity.16, 23 Interestingly, a peptidomimetic boronic acid inhibitor (cn-716) 
covalently linked to the ZIKV protease induces a conformational change in NS2B protein 
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structure, yielding a more compact ‘closed’ form, with the NS2B polypeptide wrapped around 
NS3.16 In addition, a high-resolution of 1.8 Å crystal structure of ZIKV NS2B/NS3 protease bound 
with the last four amino acids T127-G128-K129-R130 (TGKR) of the NS2B protein has also been 
solved (Figure 1A).17 This ‘TGKR’ proteolytic product could bind to S1, S2 and only partially to 
S3 pockets of the ZIKV protease through mainly charge-charge and hydrogen bonding 
interactions. More recently, the unlinked ZIKV NS2B/NS3 protease construct in apo form and 
bound form with a reversely oriented peptide has been produced and revealed by X-ray 
crystallography.24 The closed conformation of this construct suggests that NS2B is necessary for 
NS3 to generate an unoccupied substrate-binding pocket. This is distinguished from the relaxed or 
open form, as found in the NS2B-(linker)-NS3 construct23 and as has been reported for other 
flavivirus NS2B/NS3 proteases.19 Furthermore, it was observed from the study reported in ref 24 
that four amino acids K14-K15-G16-E17 (KKGE) from the neighboring NS3 could bind to the ZIKV 
protease and resist proteolytic activity. Altogether, this information has provided a good starting 
point for further design of anti-ZIKV agents with high specificity and efficiency. 
 
 
Figure 1. (A) 3D-structures of the ZIKV protease in complex with the tetrapeptide ‘TGKR’ of the 
NS2B protein (PDB ID: 5GJ4). The catalytic triad residues (D75, H51 and S135) and the co-
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crystalized tetrapeptide (orange) are shown. (B) The cleavage sites between P1 and  P1′ junction 
for each substrate are represented by red arrow.25 
 The NS2B/NS3 serine protease exhibits a preferential cleavage site of a peptide bond 
within a peptide substrate, which has an amino acid sequence commonly represented by -P4-P3-
P2-P1-P1′-P2′-P3′-P4′-. Note that the peptide bond is cleaved at the P1 and P1′ boundary by the 
enzyme (Figure 1B). With the structural similarities of flaviviral proteases to other proteins in the 
chymotrypsin family,26 it has been proposed that these enzymes should present a similar catalytic 
mechanism. Theoretical and experimental evidence provide a general reaction mechanism for 
chymotrypsin–like serine proteases composed of two steps; acylation and deacylation processes.27-
29 In the acylation step, the imidazole ring of H51 is in the position to deprotonate the nucleophilic 
hydroxyl group of S135 in the Michaelis complex (MC), and the D75 side chain is in the 
orientation to stabilize the positively charged H51 after accepting the proton from S135. 
Subsequently, the peptide bond is cleaved by a nucleophilic addition reaction on the substrate 
carbonyl carbon by the oxygen atom on the hydroxyl group of S135, generating a tetrahedral 
intermediate (TI) formation that is stabilized by hydrogen bonds with some residues of the 
oxyanion hole (formed by the backbone amides of G133 and S135). The peptide bond is then 
broken, liberating the N-terminus of the peptide substrate and acyl enzyme (AE) (Scheme 1). The 
deacylation process involves the hydrolysis reaction on the AE, leading to a release of the C-
terminus of the substrate and the catalytic residues of the enzyme. On the basis of the reaction 
mechanism proposed for serine proteases, the acylation process is considered as the rate-limiting 
step, in which the reaction rate is determined by formation of a relatively stable TI.28, 30, 31 In 
addition, for most serine proteases, the acylation process is known to be the rate-limiting step for 
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hydrolysis of amide bonds, while the deacylation process is rate-limiting step for hydrolysis of 
ester bonds.32-34  
 
Scheme 1. Proposed reaction mechanism for the reaction of the acylation process catalyzed by the 
ZIKV protease. This process involves proton transfer and nucleophilic attack, leading to the 
formation of a tetrahedral intermediate (TI), and thereafter the peptide bond breaking to produce 
acyl enzyme (AE). The QM region (labeled in blue) consists of a fragment of the catalytic residues 
(H51, D75 and S135) of the NS3 protease and its substrate. 4 hydrogen link atoms are displayed 
in a closed circle. The atomic labels involved in the reaction mechanism are also given.  
 Although serine proteases have been reviewed extensively,35-37 the structural dynamics and 
the enzymatic reaction catalyzed by ZIKV NS2B/NS3 serine protease have not been described and 
established yet. Therefore, the purpose of the current study is to gain a detailed picture of the 
dynamical behavior and the mechanistic reaction of the acylation process catalyzed by NS2B/NS3 
serine protease of ZIKV. Classical molecular dynamics (MD) simulations with a molecular 
mechanics (MM) potential function were used to explore the dynamics of the active enzyme-
substrate complex, whereas combined quantum mechanics/molecular mechanics (QM/MM) 
methods were applied to determine the mechanistic reaction for the enzymatic cleavage of 
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substrate. Here, we performed an extensive semiempirical QM/MM umbrella sampling simulation 
to elucidate the reaction energy profiles of the two steps of the acylation process catalyzed by the 
ZIKV protease. The corresponding rate-limiting step of the acylation process, which involves the 
TI formation, was further clarified from the potential energy profiles using DFT QM/MM level. 
The corrections with high level QM/MM calculations (precisely at the coupled cluster method) 
were also applied to estimate multiple QM/MM potential energy surfaces for the first step of the 
acylation process. It should be noted that coupled cluster calculations are considered as the “gold 
standard” of ab initio methods for QM/MM calculations of potential energy surfaces for enzyme 
catalysis.38 The results shown here give a detailed insight into the structural dynamics and reaction 
mechanism that could be useful for future inhibitor design based on transition state (TS) analogues. 
 
Computational Methods 
System Preparation  
The coordinates of the ZIKV protease enzyme in complex with TGKR peptide from the X-
ray structure (Protein Data Bank (PDB), code 5GJ4)17 were employed. Note that a tetrapeptide 
‘TGKR’ corresponds to the -P4-P3-P2-P1- positions of the NS2B/NS3 cleavage site, respectively. 
The carboxylate group presented on the peptide C-terminus was replaced by the P1′ serine (S) 
residue, corresponding to the NS2B/NS3-mediated cleavage site.25 The addition of missing 
hydrogen atoms and protonation states of ionizable amino acid residues were assigned at pH = 8.5, 
using the H++ server (http://biophysics.cs.vt.edu/H++),39 except for H51 which was set as the 
neutral form with protonated δ-NH (HID type) due to mechanistic consideration. In addition, their 
environments were considered based on the possibility of hydrogen bond formation with the 
surrounding residues. The ff14SB40 AMBER force field was used to assign bonded and non-
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bonded parameters to the protein and peptide substrate. The system was solvated in an octahedron 
box of TIP3P41 water model and neutralized with sodium ions (Na+),42 consisting of ~6000 water 
molecules and 3 Na+ ions. 
Molecular Dynamics Simulations 
MD simulations of the ZIKV NS2B/NS3TGKRS complex were performed with the 
AMBER16 software package coupled with the sander and pmemd modules.43 The system was 
simulated under periodic boundary conditions and the electrostatic interactions were treated using 
the Particle Mesh Ewald method.44 Temperature was maintained by the Langevin dynamics 
technique with a collision frequency of 2 ps-1,45 and pressure was controlled by the simple 
Berendsen barostat,46  with a pressure-relaxation time of 1 ps. A cut-off distance of 10 Å was set 
for non-bonded interactions, while all covalent bonds involving hydrogen atoms were constrained 
by the SHAKE47 algorithm, allowing a simulation time step of 2 fs. Prior to performing MD 
simulations, the water molecules and counter ions were energy-minimized by 1000 iterations of 
steepest descent (SD), followed by 2000 iterations of conjugate gradient (CG) methods, while the 
rest of the molecules were restrained. Afterward, the protein was energy-minimized by SD (1000 
steps) and CG (2000 steps) methods together with restrained solvent. Finally, the entire system 
was fully energy-minimized using the same minimization procedure. After an initial energy 
minimization step, the complex was slowly heated up to 300 K in 100 ps using positional restraints 
of 50.0 kcal mol-1 Å-2 for the alpha carbon (Cα) atoms of protein. The system was further 
equilibrated for 1000 ps with positional restraints, which were consequently decreased by 5.0 kcal 
mol-1 Å-2 every 100 ps, and another 100 ps without any positional restraints. Subsequently, the 
whole system was simulated under an isothermal-isobaric (NPT) ensemble for 200 ns (300 K, 1 
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atm) in three independent simulations, leading to 600 ns in total of simulation time. In addition, a 
single MD simulation was performed for the apo form for 1 µs. 
QM/MM MD Free Energy Calculations 
 QM/MM MD simulations were carried out using the sander module implemented in the 
AMBER16 package. One suitable representative conformation from the previous MM MD 
simulations that fulfilled the following criteria: (i) d(N2H2) < 2.0 Å and d(O3Cγ) < 3.0 Å, and 
(ii) the nucleophilic attack angle, θy(O3CγOγ), close to 90o, was selected as the starting 
geometry for the QM/MM simulations. The QM region consisting of 60 atoms included the side-
chains of the catalytic triad (H51, D75 and S135) and the substrate amino acids (P1 and P1′) close 
to the scissile bond (blue label in Scheme 1; see Figure 2). Moreover, a negative total charge (–
1e) was set for the QM region and 4 hydrogen link atoms (LAs)48, 49 were applied to saturate the 
QM/MM boundary. The SHAKE algorithm was not calculated in the QM region. The QM region 
was treated with the PM6 semiempirical method,50 while the remaining region was described at 
the MM level using the ff14SB force field. 
 
Figure 2. Active site of ZIKV protease with the fragment of substrate. The QM atoms and the MM 
regions are displayed as magenta and green carbon atoms, respectively. Four hydrogen link atoms 
were used to saturate the QM/MM boundary, where the color is switched from magenta to green. 
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The hydrogen bonds are represented by dashed lines. The atomic labels involved in the reaction 
mechanism are also given for further discussion. 
 QM/MM umbrella sampling MD simulations were performed for each step of the acylation 
process, harmonically restraining the reaction coordinate (RC) with a force constant of 100 kcal 
mol-1 Å-2. Each window was composed of 50 ps of restrained QM/MM MD. The RC was scanned 
at 0.1 Å intervals between adjacent windows, using the previous geometry as the starting point for 
the subsequent window. The free energy profiles for each step were calculated by the weighted 
histogram analysis method (WHAM).51-53 The acylation process was categorized into two steps, 
in which the first and second steps were defined by TI formation and the breaking of peptide bond, 
respectively. The following reaction coordinates (RCs) were used: (i) the first step of the acylation 
 a 2D umbrella sampling simulation involving the proton transfer from S135 oxygen to H51 ε 
nitrogen, defined as d(O3H2)d(N2H2), ranging from 1.0 to 1.0 Å, and the nucleophilic attack 
of S135 oxygen to the carbonyl carbon of substrate, defined as d(O3Cγ), varying from 3.0 to 1.5 
Å. In order to calculate a less constrained pathway, a 1D umbrella sampling for the reaction was 
run using a RC described by the difference of the breaking and forming bonds 
(d(O3H2)d(N2H2)d(O3Cγ), from 3.8 to 0.6 Å). For (ii) the second step of the acylation 
 2D umbrella sampling with two RCs accounting for the breaking of Cγ−Nγ peptide bond, defined 
as d(Cγ−Nγ), with values ranging from 1.5 to 1.9 Å, and the transfer of proton from the ε nitrogen 
of the H51 to the peptide bond nitrogen of the substrate, defined as d(Nγ−H2)d(N2H2), varying 
from 1.6 to 1.0 Å, was simulated. Similar to the first step of the acylation process, a single RC 
described by the antisymmetric combination of d(Cγ−Nγ) and d(Nγ−H2)d(N2H2), 
(d(Cγ−Nγ)−d(Nγ−H2)+d(N2H2), from 0.2 to 2.8 Å) was used. 
High Level QM/MM Calculations for the First Step of the Acylation Process 
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 High-level QM/MM calculations (up to the LCCSD(T) level, which can provide 
‘chemically accurate’ barriers for reactions54-56) were performed to obtain accurate potential 
energy profiles for the reaction. TS-like conformations obtained from PM6/ff14SB 1D umbrella 
sampling MD simulations were used as the starting geometries for an adiabatic mapping approach 
along the RC of d(O3H2)d(N2H2)d(O3Cγ) for the first step of the acylation process. Five 
initial geometries of TS structure were selected from 3050 ps simulation at every 5 ps of the TS-
sampling window at the PM6/ff14SB of stationary point (d(O3H2)d(N2H2)d(O3Cγ) at 1.8 
Å). To reduce the size of QM/MM calculations, all water molecules above the sphere of the protein 
were removed, and so the resulting protein was in a 10 Å layer of water surrounding protein. The 
QM region consisted of the atoms that were used in QM/MM umbrella sampling MD simulations 
as mentioned above. All protein residues plus water molecules within a 5-Å sphere of the substrate 
were included in the active region of the optimization process and allowed to move freely, while 
the rest of atoms were kept frozen. All QM/MM calculations were performed using ChemShell,57, 
58 by combining the Orca package59 for the QM part and DL_POLY60 for the MM part. A full 
electrostatic embedding scheme was employed to calculate the polarizing influence of the enzyme 
environment on the QM region. Hydrogen LAs with the charge-shift model44, 61 were applied to 
treat the QM/MM boundary. During the QM/MM geometry optimizations, all atoms in QM region 
were described at the BH&HLYP-D3/6-31G(d) level of theory. The D3 in the acronym indicates 
that an empirical dispersion correction was applied to the DFT calculations.62 The inclusion of 
dispersion correction plays an important in DFT QM and QM/MM calculations, particularly in 
those reactions catalyzed by enzymes.63, 64 The MM region was described by the ff14SB AMBER 
force field implemented in the DL_POLY code. A RC restraint was used to drive the reaction from 
the TS toward the reactant and product states at 0.1 Å intervals during the geometry optimizations. 
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Note that the BH&HLYP65-67 is known to provide better results than B3LYP65, 68, 69 for some proton 
and charge transfers56, 70 and also a better description of hydrogen bonding.71-73 In addition, the 
BH&HLYP method gave the good results in line with ab initio methods.74 Herein, single-point 
energy QM/MM calculations on the BH&HLYP-D3/6-31G(d)/ff14SB optimized geometries were 
performed at the LMP2/(aug)-cc-pVTZ/ff14SB, SCS-LMP2/(aug)-cc-pVTZ/ff14SB, and 
LCCSD(T)/(aug)-cc-pVTZ/ff14SB levels of theory using ChemShell together with MOLPRO for 
the QM region.75 SCS denotes the spin component scaled method76 applied for the MP277 
calculations. It is worth noting that the combination of SCS and MP2 calculations provided results 
in good agreement with the coupled cluster methods for the reaction mechanisms catalyzed by 
other enzymes.56, 79, 80 The (aug) in the notation of the (aug)-ccpVTZ81 basis set means that a basis 
set augmented with diffuse functions were only used for the oxygen atoms. Meanwhile, the L in 
these acronyms for the correlated ab initio methods indicates that local approximations38, 82, 83 were 
adopted in the QM/MM calculations. 
 
Results and Discussion 
MM MD Simulations 
To monitor the structural stability of the three independent MD simulations, the root-mean-
square deviation (RMSD) relative to the initial minimized structure for the backbone atoms of 
protein was evaluated and plotted along the simulation time (see Figure S1). The results show that 
the protein is stable and shows similar behavior in the three independent replicas (average RMSD 
of 1.5 Å). Upon substrate binding, the active site (residues within 4 Å of substrate) does not show 
significant structural changes caused by ligand binding, in comparison with the apo form (average 
RMSD value of 1.0 Å for all heavy atoms of residues in the active site). In addition, the structure 
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of the apo state stays in a closed conformation over the course of the simulation (1 µs), and exhibits 
a stable substrate-binding pocket, which is very similar to the X-ray crystal structure of ZIKV 
protease as a free enzyme.24 To evaluate the structural compactness at the protein active site, radius 
of gyration (Rg) of amino acids within 4 Å of substrate was calculated. The result shows relatively 
constant Rg values (average value of 8.7 Å) for both forms, reflecting a closed conformation of 
ZIKV protease (see SI, Figure S2). Representative structures for each replica in the bound state 
and apo state (obtained by cluster analysis) of the binding pocket are superimposed to illustrate 
the closed conformation of enzyme with and without substrate bound are shown in SI, Figure S3. 
Our MD simulation results support the closed conformation of ZIKV protease in both apo and 
bound forms that evidently found in the experiments based on the X-ray structures with and 
without peptide/inhibitor bound.24, 84   
Distances at the Catalytic Triad and Oxyanion Hole 
 The distances of the catalytic residues H51, D75 and S135 (d1–d3), nucleophilic attack 
(d4) and oxyanion hole constructed by the backbone amides of G133 and S135 (d5 and d6), are 
illustrated in Figure 3A. Histograms of these important distances (d1–d6) are also plotted in 
Figure 3B, where the data presented here is a combination of all three independent MD simulations 
collected from the last 100 ns of each replica. The histograms for the distances of d1 and d2 show 
a peak in the population at ~3.0 Å for d1 and ~2.7 Å for d2 (Figure 3B), as monitored from the 
carboxylate oxygen atoms (O1 and O2) of D75 to the N1-imidazole nitrogen of H51, indicating 
the presence of two hydrogen bonds. Similar to the X-Ray structures of WNV NS2B/NS3 protease 
in complex with peptide inhibitors, the O1 atom was located closer to the N1 atom than the O2 
atom (d1 of ~3.3 Å and d2 of ~2.8 Å).19, 85 The histogram of the distance between the N2-imidazole 
nitrogen of H51 and the O3-hydroxyl oxygen of S135 (d3) displays a peak at ~2.7 Å, involving 
the forming of a strong hydrogen bond and feasibly facilitating the proton transfer from S135 to 
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H51. Besides, the nucleophilic attack involving the first step of the acylation process is defined as 
the distance between the hydroxyl oxygen atom (O3) of S135 and the carbonyl carbon (Cγ) of the 
scissile peptide P1(R) position (d4). Based on the histogram for this distance, there is a maximum 
in the population at ~3.0 Å. This finding demonstrates that all three catalytic triad residues and the 
substrate are in an appropriate configuration for initiating the cleavage reaction. 
 
Figure 3. (A) Definition of the interatomic distances involved in the cleavage reaction (d1–d6). 
(B) Histograms of key interatomic distances, d1–d6, from MM MD simulations, sampling from 
100 to 200 ns. 
 The oxyanion hole of the flavivirus NS2B/NS3 protease is formed by the backbone amides 
of residues G133 and S135, which interact with the Oγ–carbonyl oxygen of the P1(R) reacting 
residue in the cleavage reaction (d5 and d6). The histograms of these two distances indicate a 
maximum in the population at ∼3.1 Å for d5 and ∼2.8 Å for d6, showing stable interactions. 
Altogether, the overall substrate conformation and interatomic interactions present in the active 
site of ZIKV NS2B/NS3 protease over the course of MD simulations are relatively similar to those 
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of the WNV NS2B/NS3 X-ray structures19, 85 and our previous MD simulations of DENV type 2 
NS2B/NS3.86 This demonstrates that the simulation models are stable.  
 In addition to these six important distances, the angles related to nucleophilic attack, 
defined as θx and θy (see SI), are measured. The histograms of both angles show a peak with the 
highest population at about 98° and 82° for θx and θy, respectively (Figure S4). These two 
calculated parameters that describe the nucleophilic attack had been introduced from the average 
value of superimposed 79 serine protease complexes with inhibitors, consistently close to 90°.87 
Additionally, the molecular geometry found in these protease-inhibitor complexes might be 
considered as a universal hypothesis of good models for the reactive MC, resulting in rapid 
progression to the AE. Therefore, both parameters, d4 and θy, would be helpful to guide in selecting 
an initial structure for the QM/MM simulations in the next step (see Methods). 
PM6/MM Free Energy Profiles 
 QM/MM approaches can be used with enhanced sampling methods, e.g. the commonly 
used umbrella sampling technique, to calculate activation free energies in good agreement with 
experimental data.88-91 Herein, we applied QM/MM (PM6/ff14SB) MD umbrella sampling 
simulations to model the reaction involving the acylation step catalyzed by the ZIKV protease and 
to map the corresponding free energy surfaces (potential of mean force, PMF). The free energy 
profiles consist of the TI formation and the breakdown of peptide bond, which are calculated by 
iteratively changing the value of a RC (typically defined as a combination of relevant interatomic 
distances; see Computational Methods). The computational time for extensive sampling is very 
costly, the use of semiempirical level is more practical. In this study, we selected the PM6 
semiempirical method to treat the QM region. PM6 has been successfully applied to study reaction 
mechanisms involved in enzyme-catalyzed reactions.92-94 Moreover, our preliminary results show 
that the energy barrier obtained at the PM6/ff14SB level of theory is in more reasonable agreement 
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with the experimental activation free energy compared to PM3, AM1/d and SCC-DFTB results. 
The resulting free energy profiles at PM6/ff14SB level are depicted in Figures 4 and 5.  
 The 2D free energy surfaces for the corresponding reaction are calculated along the RCs. 
The minimum energy path (MEP)95-97 on the surface for the first step of acylation (Figure 4A) 
shows an activation free energy (∆G‡) of 10.1 kcal mol-1 relative to the MC (TS1; Table 1). The 
apparent experimental activation free energy is ~18.2 kcal mol-1 (kcat of 0.95 s
−1 at 37 °C)98; hence, 
the PM6/ff14SB reaction barrier is too low compared to the experimental data. This is due to 
limitations of the PM6 semiempirical QM method for this reaction, as shown by higher level 
QM/MM calculations (see below).99 Afterward, this TS further evolves to the TI formation with a 
lower barrier of 7.1 kcal mol-1 relative to the MC. Only one TS is found in the first step of the 
acylation, i.e. the reaction occurs in a concerted manner,100 in which the transfer of proton from 
S135 to H51 and the nucleophilic addition of S135 oxygen to the carbonyl carbon on P1(R) of the 
substrate occur together. This is similar to the ab initio QM/MM results from MD-FEP calculations 
obtained by Kato and Ishida on trypsin.100 Moreover, the concerted reaction mechanism of the TI 
formation has been studied extensively by theoretical investigations on other serine proteases.30, 
100-104 However, this is in contrast to the QM/MM (PDDG-PM3/ff99SB) study suggesting a 
stepwise mechanism of the TI formation catalyzed by DENV type 2 NS2B/NS3 serine protease, 
in which the nucleophilic attack takes place only after the proton transfer.105 Thus, we additionally 
performed QM/MM MD umbrella sampling simulations using only one RC involving the proton 
transfer from S135 oxygen to H51 ε nitrogen (d(O3H2)d(N2H2)) in the MC. During the proton 
transfer from S135 to H51, the nucleophilic attack on the substrate happens spontaneously. 
Therefore, this is a further evidence to support a concerted mechanism. The resulting free energy 
profile at the PM6/ff14SB level has an activation barrier of 9.9 kcal mol-1 (See Figure S5), which 
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is slightly lower than that of the energy barrier obtained by using combination of the interatomic 
distances at the same level of theory (Figure 5).  Nevertheless, Warshel and colleagues suggested 
a stepwise reaction with prior proton transfer in the MC.106 Indeed, the question “How do serine 
proteases really work?”,107 is still open, and the exact sequence of steps is under debate.  
 
Figure 4. (A) 2D free energy surfaces for the TI formation and (B) the breakdown of the peptide 
bond for the reaction of the ZIKV protease with its substrate, calculated from umbrella sampling 
simulations at the PM6/ff14SB level of theory. 
Table 1. Free energies, relative to the MC, obtained at the PM6/ff14SB QM/MM level from two-
dimensional umbrella sampling MD simulations (i.e. from the free energy surfaces shown in 
Figure 4). 
 Free energy (kcal mol-1) 
MC 0.0 
TS1 10.1 
TI 7.1 
TS2 9.1 
AE 0.5 
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 Using the combination of the interatomic distances, Figure 5 shows 1D free energy profiles 
obtained from QM/MM MD 1D umbrella sampling simulations for both steps of the acylation. All 
of the intermediates and reaction energy barriers observed in 2D free energy surfaces are apparent. 
The free energy profile for the first step of the acylation has the same energy barrier of 10.1 kcal 
mol-1 with 2D free energy surfaces at the RC of ~1.8 Å. The distance calculations also support that 
the first step of the acylation process takes place in a concerted manner, as can be seen from a 
simultaneous decrease in d(N2H2) and d(O3Cγ) involving the distances of the proton transfer 
and nucleophilic attack, respectively (Figure 6A). Moreover, the alterations of the two hydrogen 
bond distances between H51 and D75, defined as d(O1H1) and d(O2H1), are monitored along 
the RC. The calculated distances show that d(O1H1) increases from ~2.0 up to ~2.4 Å at the RC 
accounting for TS1, while d(O2H1) shortens from ~2.0 to ~1.6 Å with the progress of the reaction 
(Figure 6B). This finding is described by the conformational change of the imidazole ring of H51 
that prepares its geometry to accept the proton from S135. The rotation of the H51 imidazole ring 
also results in the formation of two strong hydrogen bonds with the carboxylate group of D75. 
Apart from these two hydrogen bonds, other hydrogen bonds are also detected in the oxyanion 
hole. In the MC complex, two hydrogen bonds are formed between the carbonyl oxygen on the 
scissile substrate and the NH group of G133 and S135, defined as d(NHG133Oγ) and 
d(NHS135Oγ) (Figure 6B). As the reaction proceeds, both distances continuously decrease along 
the RC. They remain approximately constant at ~1.9 Å to stabilize negative charge centered on the 
carbonyl oxygen when the TI is formed (for comparison: the Mulliken charges of the carbonyl 
oxygen are 0.69 and 0.93 a.u. in the MC and the TI formation, respectively, Table 2). In 
addition, as expected, the Mulliken charge analysis revealed that the electronic properties of the 
N2H51 atom change from basic to acidic after receiving the proton from S135. On the other hand, 
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as the N2H51 becomes more acidic (more positive charge), the Mulliken charge on the substrate’s 
Nγ atom decreases. This event plays an important role for the peptide bond breaking in the next 
step, where the H2 hydrogen is transferred from N2H51 to the Nγ nitrogen on the TI. However, the 
atomic charge of the O3S135 atom remains approximately constant (around 0.6 a.u.) suggesting 
that the reaction proceeds by a concerted pathway rather than by a stepwise manner as mentioned 
previously. Also, this information is in good agreement with the single TS found in the 1D and 2D 
free energy profiles. 
 
 
Figure 5. 1D free energy profiles for the TI formation and the breakdown of the peptide bond 
relative to the MC for the reaction of the ZIKV NS2B/NS3 serine protease with its substrate using 
the combined RCs at the PM6/ff14SB level of QM/MM theory.  
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Figure 6. Average values of (A) the distances involving proton transfer and nucleophilic attack 
and (B) the hydrogen bond distances between QM and MM atoms along the reaction pathway. 
Table 2. Average Mulliken charges (PM6/ff14SB) in atomic units for atoms involving the 
formation of the TI, averaged from the QM/MM free energy profile. 
Relevant atom 
Mulliken charge 
MC TS1 TI 
Nγ 0.45 0.56 0.61 
Oγ 0.69 0.82 0.93 
Cγ 0.61 0.72 0.74 
N2 0.40 0.34 0.18 
H2 0.35 0.41 0.38 
O3 0.60 0.64 0.63 
 
 The free energy profile for the second step of the acylation process connecting the TI to 
the AE product is shown in Figures 4B and 5. The simulations show that the H2 atom is transferred 
from N2H51 to the substrate’s Nγ, and thereafter the peptide bond breaks. The calculated distances 
along the reaction pathway evidently show that d(NγH2) continuously decreases indicating the 
progression of the proton transfer to Nγ, while d(CγNγ) involving peptide bond breakdown 
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slightly increases up to ~1.6 Å when the AE product is formed (Figure 7). The energy difference 
between TI and TS2 is considered as the energy barrier for this step and is only 2.0 kcal mol-1. 
This value is lower than that of the barrier height observed in the TI formation, such that the TI 
formation is the rate-limiting step for the acylation process.  
 During the peptide bond breaking process, the bond between O3H51 and Cγ of the substrate 
becomes stronger, which is shown by the acyl–enzyme bond, d(O3Cγ), approaching its lowest 
value of 1.41 Å upon reaching the AE product (Figure 7). Furthermore, as the reaction progresses, 
hydrogen bonds between H51 and D75 show the similar situation as found in the first step of 
acylation involving the rotation of the imidazole ring of H51 to facilitate the proton transfer from 
N2H51 to the Nγ nitrogen on the substrate. The calculated distances demonstrate that d(O1H1) 
increases up to ~2.4 Å, whereas d(O2H1) decreases from ~2.1 to ~1.5 Å. In this event, the 
position of H2 attached to N2H51 atom is in close proximity to the Nγ nitrogen of substrate, allowing 
easy transfer the proton. The other two hydrogen bonds formed in the oxyanion hole are maintained 
along the reaction pathway, shown by the d(NHG133Oγ) and d(NHS135Oγ) distances of around 
1.9 Å. This indicates that the AE formation is still stabilized by both hydrogen bonds. It is worth 
noting that structural changes are also found in the carbonyl group on the acyl-portion. As the 
reaction progresses, the carbonyl bond length becomes shorter in AE with the similar value to that 
found in MC complex (~1.24 Å), reflecting the conversion of Cγ hybridization from a sp3 (the 
carbonyl bond length of ~1.29 Å at the TI stationary point) to a sp2 hybridization upon AE product. 
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Figure 7. Average values of the distances along the reaction pathway involving the second step of 
acylation process. Interatomic distances are shown in different colors, as indicated.  
 
Potential Energy Surface for Reaction and Effect of Basis Set Size 
 To examine the influence of the basis set on the energy profiles for the first step of the 
acylation process, single point QM/MM energy calculations were performed on the BH&HLYP-
D3/6-31G(d)/ff14SB optimized geometries (see below) using a variety of polarization and diffuse 
functions, as well as a larger basis set for the DFT method (6-311++G(d,p)) (Figure 8). The results 
show that the energy profiles are very similar in terms of shape, reaction energy barriers and 
energies of the TI formation, except for 6-31G. The BH&HLYP-D3 energy profiles calculated 
with different basis sets, including the 6-31G(d), 6-31G(d,p), 6-31+G(d), 6-31++G(d,p) and 6-
311++G(d,p) are all similar, with energy differences within 1.5 kcal mol-1 at transition states (TSs). 
The addition of polarizable functions (i.e., 6-31G(d) and 6-31G(d,p)) is clearly important for 
correct description of reaction energetics, changing the energies of the TS and TI by ∼9 kcal mol-
1, compared to the calculation with 6-31G basis set. However, additional inclusion of diffuse 
functions (i.e., 6-31+G(d) and 6-31++G(d,p)) does not significantly change the calculated 
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energies. Thus, the inclusion of only polarization functions is sufficient for giving the reasonable 
BH&HLYP-D3 energy profiles in this case; hence, the 6-31G(d) basis set provides a good choice 
for geometry optimization, balancing accuracy and computational cost. 
 
Figure 8. QM/MM energy profiles for the first step of the acylation process along the reaction 
pathway obtained at BH&HLYP-D3 QM/MM energy calculations using different basis sets for 
snapshot 1. 
Conformational Sampling and Ab Initio Energy Calculations 
 Using TS-like conformations from the 1D PMF profile as starting points, potential energy 
profiles were calculated with an adiabatic mapping procedure along the RC at the BH&HLYP-
D3/6-31G(d)/ff14SB level of theory. Afterward, ab initio QM/MM (LMP2/(aug)-cc-
pVTZ/ff14SB, SCS-LMP2/(aug)-cc-pVTZ/ff14SB and LCCSD(T)/(aug)-cc-pVTZ/ff14SB) single 
point energy calculations were used to calculate higher-level potential energy surfaces (PESs).  
As can be seen from the PESs, there are two local energy minima corresponding to the MC 
complex and the TI with a single approximate TS along the MEP at all levels of QM/MM theory 
(Figure 9). This indicates that this step of the acylation occurs in a concerted manner, as also found 
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in the PM6/MM free energy profiles. To account for conformational sampling, the results were 
averaged over multiple pathways using five different starting structures. Based on the QM/MM 
optimization at the BH&HLYP-D3/6-31G(d)/ff14SB level (Figure 9A), the average activation 
energy barrier is 19.3 kcal mol-1 (Table 3). The location of energy barrier is shifted to the product 
side at the RC of ~1.5 Å at higher level QM/MM calculations in comparison with the location of 
barrier obtained at the PM6/ff14SB level (~1.8 Å). All structures for each stationary point (i.e., 
MC, TS and TI structures) were superimposed on top of the QM/MM structures calculated at the 
BH&HLYP-D3/6-31G(d)/ff14SB level to verify the consistency of the five calculated pathways 
(Figure S6). All five of the optimized MC structures show similar configurations of the substrate 
and catalytic and important residues in the active site of enzyme. As the reaction proceeds, the 
transfer of proton from S135 to H51 and the nucleophilic attack of S135 oxygen to the carbonyl 
carbon on substrate occur simultaneously (see the detail in structural analysis section below). The 
TS and TI geometries are very similar in structure (Figure S6).  
 Single point energy calculations were performed on the geometries optimized with 
BH&HLYP-D3/6-31G(d)/ff14SB level of theory along the reaction path using LMP2, SCS-LMP2, 
and LCCSD(T) methods with the Dunning correlation consistent (aug)-cc-pVTZ basis set for the 
QM region. The results obtained for the five different initial structures with the correlated ab initio 
methods are shown in Figure 9B-D and Table 3. From conventional transition state theory 
(TST),108 the apparent activation free energy barrier from the experiment is ~18.2 kcal mol-1 
(converted from the value of kcat = 0.95 s
−1 at 37 °C).98 Note that the barriers here are activation 
potential energy that cannot be compared directly to a free energy barrier; this would require the 
calculation of the entropic, tunneling and zero-point energy contributions.109 The most accurate 
calculations here, from first principles, are at the LCCSD(T)/(aug)-cc-pVTZ level (barrier height 
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of ~16.3 kcal mol-1), which is also in good agreement with experiment (from a rough estimate of 
these additional contributions) and we use it as a reference for the comparisons. The average 
barriers from LMP2/(aug)cc-pVTZ and SCS-LMP2/(aug)cc-pVTZ are close (within 1.5 kcal mol-
1) to the LCCSD(T)/(aug)-cc-pVTZ/ff14SB results. The LMP2 result underestimates the average 
activation energy barrier compared to LCCSD(T)/(aug)-cc-pVTZ level by only 0.7 kcal mol-1, 
while SCS-LMP2 and BH&HLYP-D3 overestimate the barrier by 1.5 and 3.0 kcal mol-1, 
respectively. Meanwhile, the relative energy of the TI shows an obviously higher reaction energy 
than the MC for all levels of QM/MM calculations, indicating that formation of the TI is  a 
relatively unstable species compared to the MC, and the reaction is endothermic. The TI has 
average energies relative to the MC of 18.2 ± 1.8 kcal mol-1, 14.2 ± 1.7 kcal mol-1 and 16.1 ± 1.8 
kcal mol-1 with BH&HLYP-D3/6-31G(d), LMP2/(aug)cc-pVTZ and SCS-LMP2/(aug)cc-pVTZ, 
respectively. However, these reaction energies are larger than that of the energy obtained at the 
LCCSD(T)/(aug)-cc-pVTZ level (reaction energy of 13.0 ± 1.7 kcal mol-1). In addition, the energy 
barriers found in each snapshot linearly correlate with the reaction energies (i.e. the energy of the 
TI relative to the MC) at all levels of QM/MM theory presented here (see Figure S7). We suggest 
here that higher-level QM calculations provide significantly less deviation of the observed 
activation energy barrier and reaction energy from the LCCSD(T)/(aug)-cc-pVTZ energy 
description of the reaction. Even though the value for the BH&HLYP-D3/6-31G(d) average 
reaction barrier is higher than those of the LMP2 and SCS-LMP2 methods, it is somewhat close 
to the SCS-LMP2 value indicating that the BH&HLYP functional in combination with dispersion 
correction performs well for this particular reaction. It should be noted that dispersion-corrected 
density functional theory (DFT-D3) is very efficient to treat general intermolecular interactions at 
a reasonably accurate level and has emerged as a suitable approach for modeling the electronic 
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structure of large molecular systems.110 Moreover, BH&HLYP has been shown previously to give 
better results than the widely used B3LYP for some proton and charge transfers70 and hydrogen 
bonding.71, 73 Nevertheless, the calculation at the B3LYP-D3/6-31G(d)/ff14SB level of theory 
should be tested, as we do here. We tested by selecting three from five different starting structures 
(snapshots 1-3) to perform adiabatic mapping at this level of theory. The computed potential 
energy profiles show that the energy barrier and the reaction energy are not predicable (see Figure 
S8), suggesting that the calculation at the B3LYP-D3/6-31G(d)/ff14SB level fails to describe and 
locate the TI minimum. Additionally, the QM/MM calculations at the MP2 and SCS-MP2 levels 
with and without local approximations were tested to examine the effect of local approximations 
on their accuracy and so clarify their use at the coupled cluster level. Calculations at the (L)MP2 
and SCS-(L)MP2 levels of theory with and without local approximations show that the local 
approximations do not significantly affect the results, with the largest difference around only ∼0.5 
kcal mol-1 (see Figure S9). It can be inferred from this that local approximations introduce only 
very small errors at the LCCSD(T) level, indicating that the use of local approximations is an 
effective way to reduce computational cost to achieve coupled cluster accuracy. 
 The negative charge on the TI formation is produced from the substrate carbonyl oxygen 
atom. This high-energy species is stabilized by proton donating groups of amino acid backbone 
nearby, termed as the oxyanion hole which, in the case of flavivirus NS2B/NS3 protease, is formed 
by the backbone amide groups of G133 and S135 of the protease. It has been known that the most 
important effect of stability on the TI is the electrostatic interactions between the oxyanion hole 
region and the negatively charged carbonyl oxygen of the scissile substrate. The contributions of 
the oxyanion hole to electrostatic stabilization were evaluated at the SCS-LMP2/(aug)cc-
pVTZ/ff1SB level. The energy contribution of the oxyanion hole region was calculated by 
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subtracting the energy of the full QM region from the QM region without the residues G133, T134 
and main chain NH of S135. The oxyanion hole region stabilizes both the TS1 and TI (on average 
by ~1.5 kcal mol-1 and ~7.0 kcal mol-1 for TS1 and TI, respectively), as shown in SI (Figure S10). 
The residues of the oxyanion hole stabilize the TI significantly more than TS1, because charge is 
more localized in the TI than in the TS1, and stabilizes both relative to the neutral components in 
the MC complex. Besides, preliminarily tests of the influence of enlarging the minimal QM region 
(see Computational Methods) by an additional inclusion of the oxyanion hole region, QM/MM 
geometry optimizations on the snapshot 1 at the BH&HLYP-D3/6-31G(d)/ff14SB level were 
carried out by including fragments of G133, T134 and S135 in the QM region, leading to a total 
of 79 atoms. In the energy profiles calculated with two different sizes of the QM region (with and 
without residue fragments of oxyanion hole in the QM region), the TS1 and TI formation are found 
at almost the same values of the RC, as shown in SI (Figure S11). Furthermore, as expected, the 
computed potential energy barrier and the reaction energy were lowered by 1.8 kcal mol-1 and 2.5 
kcal mol-1, respectively for the larger QM subsystem, compared with the minimal QM subsystem. 
This is possibly due to the fact that the hydrogen bonds between the backbone amides of residues 
G133 and S135 and the carbonyl oxygen of the scissile substrate are stronger when these residues 
are treated quantum mechanically. However, it can be seen that addition of the residues located in 
the oxyanion hole that stabilize the TS1 and TI formation in the QM region does not significantly 
affect the activation and reaction energies, compared to the minimal QM subsystem. In particular, 
the difference in activation energy computed with both choices of the size of the QM region is 
relatively small (1.8 kcal mol-1), indicating that an MM treatment of the oxyanion hole region is 
still acceptable in terms of giving the similar barrier shapes and reducing computational expenses. 
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Figure 9. Potential energy profiles for the first step of the acylation process calculated at the (A) 
BH&HLYP-D3/6-31G(d)/ff14SB, (B) LMP2/(aug)-cc-pVTZ/ff14SB, (C) SCS-LMP2/(aug)-cc-
pVTZ/ff14SB, and (D) LCCSD(T)/(aug)-cc-pVTZ/ff14SB QM/MM levels. All geometries were 
optimized at the BH&HLYP-D3/6-31G(d)/ff144SB level. 
Table 3. Energy barriers (kcal mol-1) for the TI formation calculated with the BH&HLYP-D3/6-
31G(d), LMP2/(aug)-cc-pVTZ, SCS-LMP2/(aug)-cc-pVTZ, and LCCSD(T)/(aug)-cc-pVTZ 
QM/MM methodsa 
calculation 
method 
activation energy 
averagec 
snap 1b snap 2 snap 3 snap 4 snap 5 
BH&HLYP-D3 19.4 17.3 18.7 20.9 20.0 19.3 ± 1.4 
LMP2 15.5 13.4 15.1 16.9 16.6 15.6 ± 1.2 
SCS-LMP2 17.4 16.2 17.2 19.2 18.8 17.8 ± 1.2 
LCCSD(T) 16.4 14.5 15.6 17.7 17.5 16.3 ± 1.3 
a The L in these acronyms indicates that the calculation of local approximations was included in 
the ab initio methods and (aug) indicates that a basis set augmented with diffuse functions were 
only applied for the oxygen atoms. bThe conformational details of MC, TS and TI structures are 
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presented in Figure 10. cThe average value is calculated through the simple arithmetic mean of 5 
data points. 
Structural Analysis and Hints for Designing New Inhibitors 
 The geometries of the MC, TS and TI in the first step of the acylation process obtained 
from the representative snapshot 1 of the combined interatomic distances are depicted in Figure 
10. Again, it is noticeable that the two RC distances involving the formation of TI simultaneously 
decrease (d(O3H2)d(N2H2): 0.6 to 0.6 Å; and d(O3Cγ): 2.5 to 1.5 Å) during the reaction, 
reflecting a concerted reaction mechanism. Moreover, the main chain NH groups of G133 and 
S135 located in the oxyanion hole retain strong hydrogen bonding interactions with the carbonyl 
oxygen of the scissile bond and tend to exhibit the stronger electrostatic stabilization when the TI 
is formed (Figure S10). Interestingly, the step of proton transfer from S135 to H51 shows a 
complete proton transfer between the nitrogen and oxygen atoms at the transition state (TS1), as 
indicated by the decrease in d(N2H2) from 1.6 Å (MC) to 1.0 Å (TS1). At the same time, the 
oxygen nucleophilic attack on the carbon of the substrate’s carbonyl group occurs in concert with 
the proton transfer step, in which the nucleophilic attack distance, d(O3Cγ), shortens in the order 
of 2.5 Å (MC), 2.0 Å (TS1) and 1.5 Å (TI). Thus, the reaction mechanism for the TI formation 
observed in common serine proteases (e.g. trypsin and chymotrypsin) and here in ZIKV 
NS2B/NS3, is consistent with the generally accepted reaction mechanism. Nevertheless, the acyl 
enzyme hydrolysis or deacylation process is typically rate-limiting for the hydrolysis of certain 
ester substrates by several serine proteases such as chymotrypsin,111 trypsin,112 subtilisin,113 and 
elastase.114 Likewise, a kinetic study on DENV type 4 protease with its substrates revealed that the 
deacylation is rate-limiting for ester bond hydrolysis, whereas the acylation is the rate-determining 
step for amide bond hydrolysis.115 From this point of view, it can be postulated that the acylation 
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reaction is the rate-limiting step for substrate amide bond hydrolysis by ZIKV protease and thus 
the acyl enzyme hydrolysis has not been considered in this study.  
 In this present study, we have succeeded in detecting the TI, which has a very short lifetime; 
a very hard task experimentally. The determination of the reaction mechanism of ZIKV protease 
here could help to design new inhibitors based on TS analogues.116 Moreover, it seems that the 
stability of the TI can be a crucial factor in biocatalysis of several enzymes. Therefore, compounds 
which effectively mimic such an intermediate are considered as good candidates to become 
potential inhibitors of the targeted enzymes. It is worth noting that tetrahedral intermediates occur 
in many enzymes, particularly proteases and metallo-enzyme catalyzed reactions involved in 
hydrolysis of ester, amide or other acyl bonds. For instance, to resemble the tetrahedral TS of 
serine proteases, reversible covalent inhibitors able to form hemiketal formation have been 
introduced.117 This attempt has led to two FDA approved drugs, telaprevir and boceprevir, which 
are covalent inhibitors against hepatitis C virus (HCV) protease through an α-ketoamide 
warhead.118 Another example is proteasome inhibitor bortezomib that imitates the tetrahedral TS 
via boronic acid warhead and binds covalently to a threonine residue in the proteasome catalytic 
site. This inhibitor has been approved by FDA and used for treating multiple myeloma.119 One 
more example is from the discovery and development of β-lactamase inhibitors. These inhibitors 
mimic tetrahedral TS catalyzed by β-lactamase and inactivate enzyme activity.120 Similar to other 
serine proteases, β-lactamases catalyze an amide bond hydrolysis, and their catalytic mechanisms 
involve the occurrence of tetrahedral intermediates along the reaction pathway.121 Currently 
clinically approved β-lactamase inhibitors are clavulanate, tazobactam, sulbactam, avibactam and 
vaborbactam.122 In the case of ZIKV protease, potential inhibitors could form a covalent bond 
through their warheads with the catalytic residue S135 and mimic the TI structure. Development 
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of peptidomimetic inhibitors has been successful, and some of them derived from flavivirus 
protease substrates have been shown to be active toward both WNV and DENV proteases.123-125 
In addition, some of the available inhibitors against WNV and DENV proteases have also been 
shown to be active toward ZIKV protease.16, 84 This is due to the high structural similarities among 
DENV, WNV, and ZIKV proteases.126,19, 23 Structures of ZIKV NS2B/NS3 serine protease 
complexed with several inhibitors are available, which assist antiviral inhibitor design.16, 17, 24 For 
example, the dipeptidic inhibitor acyl-KR-aldehyde derived from P1 and P2 residues of the 
substrate is a potent competitive inhibitor, in which the aldehyde moiety forms a covalent bond 
with the catalytic S135 of NS3.84 Although it shows high ligand efficiency,  it is a big challenge 
in developing them into drug-like molecules and for use in clinical applications because of their 
limitations such as cell penetration and stability caused by their positive charge,84 which has 
stimulated medicinal chemists to further find new inhibitors.127, 128 Small-molecule inhibitors such 
as pyrazole ester derivatives identified from high-throughput screening of a small molecule library 
from the National Institutes of Health are much more interesting in terms of drug-likeness with 
small-molecular weight molecules and being potent inhibitors against both WNV and DENV 
proteases.129, 130 Recently, one of the pyrazole ester derivatives, namely 5-amino-1-((4-
methoxyphenyl)sulfonyl)-1H-pyrazol-3-yl benzoate, in complex with ZIKV protease has been 
revealed by crystallographic study, in which the benzoyl moiety of this compound could form a 
covalent bond with the catalytic residue S135.131 These examples provide structural information 
for covalent inhibitor design. Simulations such those presented here can help guide design132 of 
efficient protease inhibitors against ZIKV and other flaviviruses. 
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Figure 10. QM/MM (BH&HLYP-D3/6-31G(d)/ff14SB) optimized structures of the Michaelis 
complex (MC), transition state (TS1), and tetrahedral intermediate (TI) in the active site of ZIKV 
NS2B/NS3 protease obtained from the combined interatomic distances (in Å) for snapshot 1. 
 
Conclusions 
 In this present study, QM/MM methods have elucidated the reaction mechanism of the 
acylation process of ZIKV protease and its substrate cleavage reaction. Although the reaction 
mechanism of common serine proteases has been widely studied, understanding the mechanistic 
details of the reaction catalyzed by ZIKV NS2B/NS3 serine protease is still necessary to provide 
fundamental knowledge of catalysis and may also help in the design and development of potential 
antiviral agents using TS analogues. 
 By combining MM MD simulations, QM/MM MD free-energy simulations and QM/MM 
adiabatic mapping, we investigated ZIKV protease in terms of both dynamical and mechanistic 
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properties. Our results show that the mechanism of the acylation reaction catalyzed by ZIKV 
protease behaves according to the proposed reaction mechanism for general serine proteases. Only 
one TS is determined along the reaction pathway suggesting a concerted reaction mechanism, in 
which the transfer of proton from S135 to H51 takes place in synchrony with the nucleophilic 
attack on the substrate. The formation of the TI is the rate-determining step of the acylation 
process. The calculations reveal that the PM6/ff14SB level underestimates the activation free 
energy in comparison with experimentally determined apparent catalytic rate, but even so the 
barrier shapes have been found to be similar to those of other serine proteases.30, 100-104, 133 Thus, 
we have performed multiple fully optimized potential energy profiles for the first step of the 
acylation, using the correlated ab initio QM/MM methods to obtain accurate energetics. We have 
optimized geometries with BH&HLYP-D3/6-31G(d)/ff14SB level of theory. Similar to the free 
energy profiles, the formation of TI is concluded to occur through a concerted manner that involves 
a single transition state (TS1), where a stable species of TI has been found at all levels of theory. 
The potential energy barriers are 16.3 kcal mol-1 at the LCCSD(T)/(aug)-cc-
pVTZ/ff14SB//BH&HLYP-D3/6-31G(d)/ff14SB level of theory. DFT and ab initio results 
presented here are reasonably close to the coupled cluster energies. The LMP2 result slightly 
underestimates the barrier compared to the BH&HLYP-D3 and SCS-LMP2 results. However, 
these results are in good agreement with the apparent experimental free energy of the activation of 
~18.2 kcal mol-1 (at 310 K). It is indeed of significance that potential energy barriers here cannot 
directly be compared to activation free energies derived from experimental kinetics data. This is 
due to the fact that the activation free energies include additional effects such as entropy and 
quantum tunneling.55  
35 
 
 By comparisons with the most accurate (LCCSD(T)/(aug)-cc-pVTZ/ff14SB) results, 
although the BH&HLYP-D3/6-31G(d) result gives a good description, the ab initio LMP2/(aug)-
cc-pVTZ and SCS-LMP2/(aug)-cc-pVTZ methods give results much more similar to the 
LCCSD(T) result. We suggest that it is necessary to use higher-level QM methods for obtaining 
accurate energetics (precisely at the coupled cluster level, or the more practicable, SCS-LMP2) for 
ZIKV protease and for other related enzymes having the similar reaction mechanism. We hope 
that this computational information can be a good starting point to design and develop novel 
inhibitors toward ZIKV protease and other flavivirus proteases based on TS analogues. 
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